April 13, 2021 — The FDA and CDC on Tuesday really useful that use of the Johnson & Johnson COVID-19 be paused after studies of blood clots in sufferers receiving the shot, the FDA and CDC introduced Tuesday.
In a press release, FDA stated 6.eight million doses of the J&J vaccine have been administered and the company is investigating six reported instances of a uncommon and extreme blood clot occurring in sufferers who acquired the vaccine.
The CDC will convene a gathering of the Advisory Committee on Immunization Practices on Wednesday to evaluate the instances.
“That is necessary to make sure that the well being care supplier group is conscious of the potential for these opposed results and may plan as a result of distinctive remedy required with any such blood clot,” the FDA stated on Twitter.
The company plans a 10 a.m. information convention to debate the state of affairs additional. Examine again for extra protection.